Welcome to Xention
Xention is applying its expertise in ion channel drug discovery to develop novel therapies to address areas of significant unmet medical need.
The Company has a pipeline of drug candidates in atrial fibrillation, overactive bladder and autoimmune disease.
Xention Announces Attendance at Three Upcoming Conferences
14 September 2009
Xention is pleased to announce that it will be presenting at three investor
Read More
Xention Annual Report 2008